metricas

Medicina Clínica

Sugerencias
Medicina Clínica Rinitis alérgica
Información de la revista
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Visitas
3929
Revisión

Rinitis alérgica

Allergic rhinitis
Visitas
3929
Victoria Cardona
Autor para correspondencia
victoria.cardona@vallhebron.cat

Autor para correspondencia.
, Arnau Salvany-Pijuan, Javier Pereira-González
Servicio de Alergología, Hospital Vall d’Hebron, Barcelona, España
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Resumen

La rinitis alérgica es una inflamación de la mucosa nasal causada por la inmunoglobulina E, con síntomas como estornudos, picor nasal, congestión y secreción. Se asocia a menudo con conjuntivitis y asma, afectando significativamente la calidad de vida. Se recomienda una atención integrada que abarque desde la farmacia y atención primaria hasta la especializada para los casos graves o mal controlados. El tratamiento incluye evitar los alérgenos y usar fármacos como antihistamínicos y corticoides intranasales. Las combinaciones de ambos en un mismo nebulizador nasal han mostrado mayor eficacia. En casos graves, la inmunoterapia es efectiva si se ajusta al alérgeno causal. Herramientas como las escalas visuales y las aplicaciones móviles facilitan el seguimiento y el manejo de la rinitis, optimizando la atención y mejorando la autogestión del paciente. En esta revisión narrativa se abordarán todos estos aspectos.

Palabras clave:
Alergia
Rinitis
Rinoconjuntivitis
Antihistamínicos
Corticosteroides intranasales
Inmunoterapia con alérgenos
Abstract

Allergic rhinitis is an inflammation of the nasal mucosa caused by immunoglobulin E, presenting with symptoms such as sneezing, nasal itching, congestion, and rhinorrhea. It is often associated with conjunctivitis and asthma, significantly impacting quality of life. An integrated care approach is recommended, spanning from pharmacy and primary care to specialized care for severe or poorly controlled cases. Treatment includes avoiding allergens and using medications like antihistamines and intranasal corticosteroids. Combinations of these medications in a single intranasal spray have shown greater efficacy. In severe cases, immunotherapy is effective if tailored to the causing allergen. Tools like visual analogue scales and mobile applications facilitate monitoring and management of rhinitis, optimizing care and improving patient self management. In this narrative review, all these aspects will be addressed.

Keywords:
Allergy
Rhinitis
Rhinoconjunctivitis
Antihistamines
Intranasal corticosteroids
Allergen immunotherapy

Artículo

Opciones para acceder a los textos completos de la publicación Medicina Clínica
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Bibliografía
[1]
S.K. Wise, C. Damask, L.T. Roland, C. Ebert, J.M. Levy, S. Lin, et al.
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.
Int Forum Allergy Rhinol, 8 (2018), pp. 108-352
[2]
M.S. Dykewicz, D.V. Wallace, F. Baroody, J. Bernstein, T. Craig, I. Finegold, et al.
Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update.
Ann Allergy Asthma Immunol, 119 (2017), pp. 489-511.e41
[3]
P. Huber, M. Gröger, C. Stihl, H. Frankenberger, M. Bertlich, F. Haubner, et al.
Diagnostics of allergic rhinitis under dupilumab therapy.
Eur Arch Otorhinolaryngol, 281 (2024), pp. 4183-4190
[4]
J.L. Brożek, J. Bousquet, I. Agache, A. Agarwal, C. Bachert, S. Bosnic-Anticevich, et al.
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision.
J Allergy Clin Immunol, 140 (2017), pp. 950-958
[5]
V. Plaza Moral, I. Alobid, C. Álvarez Rodríguez, M. Blanco Aparicio, J. Ferreira, G. García, et al.
GEMA 5.3 Spanish Guideline on the Management of Asthma.
Open Respir Arch, 5 (2023), pp. 100277
[6]
P. Ojeda, M.D. Ibáñez, J.M. Olaguibel, J. Sastre, T. Chivato.
investigators participating in the National Survey of the Spanish Society of Allergology and Clinical Immunology Alergológica 2015 Alergológica 2015: A National Survey on Allergic Diseases in the Spanish Pediatric Population.
J Investig Allergol Clin Immunol, 28 (2018), pp. 321-329
[7]
Y. Zhang, F. Lan, L. Zhang.
Update on pathomechanisms and treatments in allergic rhinitis.
Allergy, 77 (2022), pp. 3309-3319
[8]
K. Okubo, Y. Kurono, K. Ichimura, T. Enomoto, Y. Okamoto, H. Kawauchi, et al.
Japanese guidelines for allergic rhinitis 2017.
Allergol Int Off J Jpn Soc Allergol, 66 (2017), pp. 205-219
[9]
D.I. Bernstein, G. Schwartz, J.A. Bernstein.
Allergic Rhinitis: Mechanisms and Treatment.
Immunol Allergy Clin North Am, 36 (2016), pp. 261-278
[10]
W.J. Fokkens, V.J. Lund, C. Hopkins, P.W. Hellings, R. Kern, S. Reitsma, et al.
European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
Rhinology, 58 (2020), pp. 1-464
[11]
T.M. Laidlaw, J. Mullol, K.M. Woessner, N. Amin, L.P. Mannent.
Chronic Rhinosinusitis with Nasal Polyps and Asthma.
J Allergy Clin Immunol Pract, 9 (2021), pp. 1133-1141
[12]
C. Beutner, S. Traidl, M. Wagenmann, M.M. Hollstein, D. Beutner, M.P. Schön, et al.
Dupilumab Improves Clinical Symptoms and Biomarkers in Comorbid Seasonal Timothy Grass Pollen Allergic Rhinitis in Patients With CRSwNP.
Clin Exp Allergy, 55 (2025), pp. 196-198
[13]
O. Luengo, M. Labrador-Horrillo.
Molecular Allergy Diagnosis in Clinical Practice: Frequently Asked Questions.
J Investig Allergol Clin Immunol, 32 (2022), pp. 1-12
[14]
A. Testera-Montes, R. Jurado, M. Salas, I. Eguiluz-Gracia, C. Mayorga.
Diagnostic Tools in Allergic Rhinitis.
Front Allergy, 2 (2021), pp. 721851
[15]
N.W.B. Wahid, C. Shermetaro.
Rhinitis Medicamentosa. In: StatPearls.
StatPearls Publishing, (2024.),
[16]
A. Valero, M. Ferrer, J. Sastre, A.M. Navarro, L. Monclús, E. Martí-Guadaño, et al.
A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items.
J Allergy Clin Immunol, 120 (2007), pp. 359-365
[17]
A. Testera-Montes, R. Jurado, M. Salas, I. Eguiluz-Gracia, C. Mayorga.
Diagnostic Tools in Allergic Rhinitis.
Front Allergy, 2 (2021), pp. 721851
[18]
A. Bozek, J. Zalejska Fiolka, A. Krajewska Wojtys, B. Galuszka, A. Cudak.
Potential Differences between Local and Systemic Allergic Rhinitis Induced by Birch Pollen.
Int Arch Allergy Immunol, 181 (2020), pp. 831-838
[19]
J.J. Bousquet, H.J. Schünemann, A. Togias, M. Erhola, P.W. Hellings, T. Zuberbier, et al.
Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases.
Clin Transl Allergy., 9 (2019), pp. 44
[20]
J. Bousquet, H.J. Schünemann, A. Togias, C. Bachert, M. Erhola, P.W. Hellings, et al.
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment Development and Evaluation (GRADE) and real-world evidence.
J Allergy Clin Immunol, 145 (2020), pp. 70-80.e3
[21]
C. Zuiani, A. Custovic.
Update on House Dust Mite Allergen Avoidance Measures for Asthma.
Curr Allergy Asthma Rep, 20 (2020), pp. 50
[22]
K. Head, K. Snidvongs, S. Glew, G. Scadding, A.G. Schilder, C. Philpott, et al.
Saline irrigation for allergic rhinitis Cochrane ENT Group, ed.
Cochrane Database Syst Rev, (2018), pp. 2018
[23]
M.S. Dykewicz, D.V. Wallace, D.J. Amrol, F.M. Baroody, J.A. Bernstein, T.J. Craig, et al.
Rhinitis 2020: A practice parameter update.
J Allergy Clin Immunol, 146 (2020), pp. 721-767
[24]
B. Sousa-Pinto, R.J. Vieira, J. Brozek, A. Cardoso-Fernandes, N. Lourenço-Silva, R. Ferreira-da-Silva, et al.
Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis.
J Allergy Clin Immunol, 154 (2024), pp. 340-354
[25]
G.K. Scadding, H.H. Kariyawasam, G. Scadding, R. Mirakian, R.J. Buckley, T. Dixon, et al.
BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007).
Clin Exp Allergy, 47 (2017), pp. 856-889
[26]
K. Yanai, T. Yoshikawa, A. Yanai, T. Nakamura, T. Iida, R. Leurs, et al.
The clinical pharmacology of non-sedating antihistamines.
Pharmacol Ther, 178 (2017), pp. 148-156
[27]
E. Meltzer, P. Ratner, C. Bachert, W. Carr, W. Berger, G.W. Canonica, et al.
Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis.
Int Arch Allergy Immunol, 161 (2013), pp. 369-377
[28]
R.S. Kumar, M.K. Jain, J.S. Kushwaha, S. Patil, V. Patil, S. Ghatak, et al.
Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion.
J Asthma Allergy, 15 (2022), pp. 783-792
[29]
G. Roberts, O. Pfaar, C.A. Akdis, I.J. Ansotegui, S.R. Durham, R. Gerth van Wijk, et al.
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.
Allergy, 73 (2018), pp. 765-798
[30]
P.M. Matricardi, S. Dramburg, E. Potapova, C. Skevaki, H. Renz.
Molecular diagnosis for allergen immunotherapy.
J Allergy Clin Immunol, 143 (2019), pp. 831-843
[31]
C. Cavaliere, E. Begvarfaj, C. Incorvaia, B. Sposato, M. Brunori, A. Ciofalo, et al.
Long-term omalizumab efficacy in allergic rhinitis.
Immunol Lett, 227 (2020), pp. 81-87
[32]
A.S. Paller, J.M. Spergel, P. Mina-Osorio, A.D. Irvine.
The atopic march and atopic multimorbidity: Many trajectories, many pathways.
J Allergy Clin Immunol, 143 (2019), pp. 46-55
[33]
E. Nappi, G. Paoletti, L. Malvezzi, S. Ferri, F. Racca, M.R. Messina, et al.
Comorbid allergic rhinitis and asthma: Important clinical considerations.
Expert Rev Clin Immunol, 18 (2022), pp. 747-758
[34]
S. Lohia, R.J. Schlosser, Z.M. Soler.
Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: A meta-analysis.
Allergy, 68 (2013), pp. 569-579
[35]
C. Cingi, P. Gevaert, R. Mösges, C. Rondon, V. Hox, M. Rudenko, et al.
Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report.
Clin Transl Allergy, 7 (2017), pp. 17
[36]
S.H. Sicherer, C.M. Warren, C. Dant, R.S. Gupta, K.C. Nadeau.
Food Allergy from Infancy Through Adulthood.
J Allergy Clin Immunol Pract, 8 (2020), pp. 1854-1864
[37]
M.H. Knudgaard, T.H. Andreasen, N. Ravnborg, T. Bieber, J.I. Silverberg, A. Egeberg, et al.
Rhinitis prevalence and association with atopic dermatitis.
Ann Allergy Asthma Immunol, 127 (2021), pp. 49-56.e1
[38]
P. Capucilli, D.A. Hill.
Allergic Comorbidity in Eosinophilic Esophagitis: Mechanistic Relevance and Clinical Implications.
Clin Rev Allergy Immunol, 57 (2019), pp. 111-127
[39]
G. Ram, J. Lee, M. Ott, T.F. Brown-Whitehorn, A. Cianferoni, M. Shuker, et al.
Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis.
Ann Allergy Asthma Immunol, 115 (2015), pp. 224-228.e1
[40]
S. Marcus, L.T. Roland, J.M. DelGaudio, S.K. Wise.
The relationship between allergy and chronic rhinosinusitis.
Laryngoscope Investig Otolaryngol, 4 (2019), pp. 13-17
[41]
C. Calvo-Henriquez, E. di Corso, I. Alobid, E. Cantone, T. di Cesare, J. Mullol.
Pathophysiological Link Between Chronic Rhinosinusitis and Ear Disease.
Curr Allergy Asthma Rep, 23 (2023), pp. 389-397
[42]
C. Colás, M. Brosa, E. Antón, J. Montoro, A. Navarro, M.T. Dordal, et al.
Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: The FERIN Study.
Allergy, 72 (2017), pp. 959-966
[43]
P. Katsimpris, G. Tripsianis, A. Printza, E. Giotakis, E. Simopoulos, J. Constantinidis, et al.
The Rhinoconjunctivitis Quality of Life Questionnaire and its modified short version validation in adults and children with allergic rhinitis.
J Laryngol Otol, 136 (2022), pp. 341-348
[44]
R. Muñoz-Cano, P. Ribó, G. Araujo, E. Giralt, J. Sanchez-Lopez, A. Valero.
Severity of allergic rhinitis impacts sleep and anxiety: Results from a large Spanish cohort.
Clin Transl Allergy, 8 (2018), pp. 23
[45]
J. Liu, X. Zhang, Y. Zhao, Y. Wang.
The association between allergic rhinitis and sleep: A systematic review and meta-analysis of observational studies.
PLoS One, 15 (2020), pp. e0228533
[46]
M.S. Dykewicz, D.V. Wallace, S. Bandi, M. Mahdavinia, A.R. Sedaghat.
Patient-Reported Outcome Measures in Rhinitis and Chronic Rhinosinusitis.
J Allergy Clin Immunol Pract, 12 (2024), pp. 2574-2582
[47]
A. Valero, I. Izquierdo, J. Sastre, A.M. Navarro, E. Baró, E. Martí-Guadaño, et al.
ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications.
J Investig Allergol Clin Immunol, 23 (2013), pp. 14-19
[48]
P.M. Matricardi, S. Dramburg, A. Alvarez-Perea, D. Antolín-Amérigo, C. Apfelbacher, M. Atanaskovic-Markovic, et al.
The role of mobile health technologies in allergy care: An EAACI position paper.
Allergy, 75 (2020), pp. 259-272
[49]
E. Verhoeven, P. Rouadi, E.A. Jaoude, M. Abouzakouk, I. Ansotegui, M. Al-Ahmad, et al.
Digital tools in allergy and respiratory care.
World Allergy Organ J, 15 (2022), pp. 100661
asdasdasd
Opciones de artículo
Herramientas